Hans J. Hansen
-
- Monoclonal and Polyclonal Antibodies Research 64
- Radiopharmaceutical Chemistry and Applications 54
- Oncology top 1%
- Peptidase Inhibition and Analysis 13
- HER2/EGFR in Cancer Research 9
-
- Lymphoma Diagnosis and Treatment 15
- Immunology top 2%
- Toxin Mechanisms and Immunotoxins 8
- Genetics top 2%
-
- Glycosylation and Glycoproteins Research 12
-
- Synthesis and Biological Evaluation 10
- Co-authors
- David M. GoldenbergGary L. GriffithsRhona SteinJohn KrupeyPaul Lo GerfoSerengulam V. GovindanRosalyn D. BlumenthalThomas M. Cardillo
- Partner nations
- United StatesDenmarkSwitzerland
In The Last Decade
Hans J. Hansen
113 papers receiving 5.4k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Radiology, Nuclear Medicine and Imaging 2.9k
- Oncology 1.9k
- Pathology and Forensic Medicine 1.2k
- Immunology 1.0k
- Genetics 413
Countries citing papers authored by Hans J. Hansen
This map shows the geographic impact of Hans J. Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans J. Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans J. Hansen more than expected).
Fields of papers citing papers by Hans J. Hansen
This network shows the impact of papers produced by Hans J. Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans J. Hansen. The network helps show where Hans J. Hansen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hans J. Hansen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 86 | |
| 2 | Therapy of human colonic and lung cancer xenografts with SN-38 conjugates of anti-CEACAM5 and anti-EGP-1 humanized monoclonal antibodies | 2007 | 3 |
| 3 | Construction, characterization, and mammalian expression of an immunotoxin consisting of ranpirnase (Rap) fused to a humanized anti-EGP-1 antibody, hRS7, as a potential therapeutic for prostate cancer | 2005 | 2 |
| 4 | 2005 | 40 | |
| 5 | 2004 | 33 | |
| 6 | 2001 | 15 | |
| 7 | 2001 | 12 | |
| 8 | 1999 | 3 | |
| 9 | 1997 | 70 | |
| 10 | 1997 | 42 | |
| 11 | 1996 | 26 | |
| 12 | 1993 | 67 | |
| 13 | 1993 | 55 | |
| 14 | 1992 | 52 | |
| 15 | 1992 | 19 | |
| 16 | 1990 | 14 | |
| 17 | 1989 | 63 | |
| 18 | Localization of GW-39 human tumors in hamsters by affinity-purified antibody to carcinoembryonic antigen. | 1977 | 49 |
| 19 | Antibody to carcinoembryonic antigen in hamsters bearing GW-39 human tumors. | 1976 | 13 |
| 20 | 1966 | 2 |
About Hans J. Hansen
Hans J. Hansen is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pathology and Forensic Medicine, having authored 114 papers that have together received 5.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (64 papers), Radiopharmaceutical Chemistry and Applications (54 papers), Lymphoma Diagnosis and Treatment (15 papers), Peptidase Inhibition and Analysis (13 papers), Glycosylation and Glycoproteins Research (12 papers), Synthesis and Biological Evaluation (10 papers), HER2/EGFR in Cancer Research (9 papers) and Toxin Mechanisms and Immunotoxins (8 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (2.9k citations), Oncology (1.9k citations) and Pathology and Forensic Medicine (1.2k citations). Hans J. Hansen has collaborated with scholars based in United States, Denmark and Switzerland. Frequent co-authors include David M. Goldenberg, Gary L. Griffiths, Rhona Stein, John Krupey, Paul Lo Gerfo, Serengulam V. Govindan, Rosalyn D. Blumenthal, Thomas M. Cardillo, Robert M. Sharkey and Ivan D. Horak. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.